Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Possible Association Between Pseudoexfoliation Syndrome, Sarcopenia and Chronic Pain

Authors not listed

Eskisehir Osmangazi University · 2023

Dysbiosis Partial reprogramming (OSK) Human Randomized controlled trial

Abstract

Aim: Pseudoexfoliation syndrome (PEX) is a systemic disease of connective tissue, it can also contribute to sarcopenia and chronic musculoskeletal pain with common pathways. 1. First aim of this study was to investigate whether the rate of sarcopenia is higher in patients with PEX 2. Second aim was to investigate the association between PEX, sarcopenia parameters and chronic musculoskeletal pain. Methods: A total of 96-patients were enrolled in this study and divided into two groups: PEX-positive (n=48) and PEX-negative (n=48) patients. The variables: the demographic data, sarcopenia parameters (SARC-F-questionnaire, hand-grip strength, chair-rise test, gait speed) and pain parameters (having any chronic musculoskeletal pain, pain regions and visual analogue scale-pain).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-18 MST

Cite this

APA

Anonymous. (2023). A Possible Association Between Pseudoexfoliation Syndrome, Sarcopenia and Chronic Pain. <em>Eskisehir Osmangazi University</em>. https://clinicaltrials.gov/study/NCT06121154

Vancouver

Anonymous. A Possible Association Between Pseudoexfoliation Syndrome, Sarcopenia and Chronic Pain. Eskisehir Osmangazi University. 2023.

BibTeX

@misc{anon2023APossi, title = {A Possible Association Between Pseudoexfoliation Syndrome, Sarcopenia and Chronic Pain}, author = {Anonymous}, journal = {Eskisehir Osmangazi University}, year = {2023}, }